AdvisorShares Pure US Cannabis ETF
|
- Description
- Performance
- Comps
- Fundamentals
- Valuation
- Rating
MSOS is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry. |
Category | US Equities |
Fund Sponsor | AdvisorShares |
Website | advisorshares.com |
Inception date | Sep 01, 2020 |
Assets (mns) | $981 |
Currency | USD |
Expense ratio | 83 bp |
Distributions | Annually |
Regulation | Open-Ended Fund |
Custodian | |
Weighting | Proprietary |
Index replication | |
Uses derivatives | No |
Options available | Yes |
No. of constituents | 93 |
Wgt avg mkt cap (mns) | $137 |
Large cap (>$10bn) | 0.0% |
Mid cap ($2-10bn) | 53.8% |
Small cap (<$2bn) | 46.2% |
Developed mkts | 100.0% |
Emerging mkts | 0.0% |
CURALEAF HOLDINGS, INC. | 4.7 % |
TERRASCEND CORP. | 4.0 % |
CANOPY RIVERS, INC. CLASS A | 0.0 % | Total | 8.7 % |
---|
UNITED STATES | 4.7 % | |
CANADA | 4.0 % |
HISTORICAL PERFORMANCE
Custom date range | Compare to | ||
thru |
Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
22.7% | 51.2% | -- | -- | -23.4% |
versus... | Beta | R-squared |
S&P500 | 1.65 | 27% |
MSCI EAFE | 1.37 | 17% |
MSCI Emg. Mkts. | 0.78 | 6% |
Recent close | $8.89 |
30d moving avg. | $6.71 |
Annualized volatility | 56.5% |
Short interest (ETF) | 19.5% |
Short interest (Underlying) | 1.1% |
Relative strength (RSI) | 58 |
Avg. volume (thou.) | 12,190 |
Turnover | 11.1% |
Bid/Ask (% of price) | 0.17% |
ADV underlying (mns) | $4 |
FINDING ALTERNATIVE FUNDS
Below is a list of 3 potential alternatives to the AdvisorShares Pure US Cannabis ETF ETF based on the alternatives' overlap in portfolio holdings with MSOS. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
Benchmark ticker: | MSOS | Expense: | 83 bp | ALTAR Score™: | -107.9% |
Ticker | Fund Name |
Overlap1 vs MSOS (%) |
Expense ratio (bp) |
Savings vs MSOS (bp) |
ALTAR Score™ (%) |
ALTAR vs MSOS (%) |
CNBS | Amplify Seymour Cannabis ETF | 8.7 | 75 | 8 | -26.3 | +81.6 |
YOLO | AdvisorShares Pure Cannabis ETF | 0.0 | 103 | -20 | -26.5 | +81.4 |
DFAX | Dimensional World ex U.S. Core Equity 2 ETF | 0.0 | 30 | 53 | 7.6 | +115.5 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | |
---|---|---|---|---|---|---|---|
Sales per share | ** | ** | ** | ** | ** | ** | ** |
Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share | ** | ** | ** | ** | ** | ** | ** |
Book value per share | ** | ** | ** | ** | ** | ** | ** |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
Long term EPS growth est. | **% | Debt-to-equity | **x | |
Asset turnover | **% | Assets-to-equity | **x |
*Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
2023 | 2024E | 2025E | |
---|---|---|---|
Price-to-sales | ** | ** | ** |
Price-to-earnings | ** | ** | ** |
Price-to-cash flow | ** | ** | ** |
Price-to-growth | ** | ** | ** |
Price-to-book value | ** | ** | ** |
Yield | ** | ** | ** |
Historical valuation trends
Forward multiple: |
AdvisorShares Pure US Cannabis ETF | |||
Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
ALTAR Score™
|
MODERN PORTFOLIO THEORY
|
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|